Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating Activities:      
Net income $ 1,066 $ 598 $ 650
Less: (Income) loss from discontinued operations, net of tax (775) (169) 39
Income from continuing operations 291 429 689
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Equity in income of investment in unconsolidated affiliates (42) (54) (55)
Unrealized losses on fair value adjustments to Venator investment and related loss on disposal 88 19 62
Cash received from return on investment in unconsolidated subsidiary 19 24 0
Depreciation and amortization 283 270 255
Noncash lease expense 63 55 0
(Gain) loss on disposal of businesses/assets (281) (49) 3
Loss on early extinguishment of debt 0 23 3
Noncash restructuring and impairment charges (credits) 7 3 (22)
Deferred income taxes 172 (93) (167)
Stock-based compensation 27 29 27
Other, net 8 20 3
Changes in operating assets and liabilities:      
Accounts and notes receivable 100 138 (22)
Inventories 145 77 (80)
Prepaid expenses (10) (27) (9)
Other current assets (55) 53 59
Other noncurrent assets (55) (90) (41)
Accounts payable 32 21 12
Accrued liabilities (126) (50) 44
Taxes paid on Chemical Intermediates Businesses (231) 0 0
Other noncurrent liabilities (158) (142) (57)
Net cash provided by operating activities from continuing operations 277 656 704
Net cash (used in) provided by operating activities from discontinued operations (24) 241 503
Net cash provided by operating activities 253 897 1,207
Investing Activities:      
Capital expenditures (249) (274) (251)
Cash received from sale of businesses 2,181 0 0
Cash received from the sale of Venator shares 99 0 0
Acquisition of businesses, net of cash acquired (650) 0 (366)
Proceeds from sale of assets 75 50 0
Cash received from forward swap contract related to the sale of investment in Venator 0 16 3
Other 6 7 (1)
Net cash provided by (used in) investing activities from continuing operations 1,462 (201) (615)
Net cash provided by (used in) investing activities from discontinued operations 1 (59) (358)
Net cash provided by (used in) investing activities 1,463 (260) (973)
Financing Activities:      
Net (repayments) borrowings on revolving loan facilities (203) (89) 125
Repayments of long-term debt (21) (676) (68)
Proceeds from issuance of long-term debt 0 742 0
Repayments of short-term debt (109) 0 (8)
Borrowings on short-term debt 0 102 6
Repayments of notes payable (32) (27) (29)
Borrowings on note payable 0 37 27
Debt issuance costs paid 0 (8) (4)
Costs of early extinguishment of debt 0 (21) 0
Dividends paid to common stockholders (144) (150) (156)
Dividends paid to noncontrolling interests (44) (41) (69)
Cash paid for noncontrolling interest 0 (101) 0
Repurchase of common stock (96) (208) (277)
Repurchase and cancellation of stock awards (8) (12) (30)
Proceeds from issuance of common stock 3 2 17
Proceeds from the secondary offering of Venator 0 0 44
Other (1) 0 (2)
Net cash used in financing activities (655) (450) (424)
Effect of exchange rate changes on cash 7 (2) (35)
Increase (decrease) in cash, cash equivalents and restricted cash 1,068 185 (225)
Cash, cash equivalents and restricted cash from continuing operations at beginning of period 525 340 481
Cash, cash equivalents and restricted cash from discontinued operations at beginning of period 0 0 238
Deconsolidation of cash, cash equivalents and restricted cash from Venator 0 0 (154)
Cash, cash equivalents and restricted cash at end of period 1,593 525 340
Supplemental cash flow information:      
Cash paid for interest 90 111 163
Cash paid for income taxes 316 100 179
Revenues:      
Total revenues [1] 6,018 6,797 7,604
Cost of goods sold 4,918 5,415 5,840
Gross profit 1,100 1,382 1,764
Operating expenses:      
Selling, general and administrative 775 786 789
Research and development 135 137 145
Restructuring, impairment and plant closing costs (credits) 49 (41) (7)
Merger costs 0 0 2
Gain on sale of India-based DIY business (247) 0 0
Other operating (income) expense, net (45) 31 8
Total operating expenses 667 913 937
Operating income 433 469 827
Interest expense, net (86) (111) (115)
Equity in income of investment in unconsolidated affiliates 42 54 55
Fair value adjustments to Venator investment and related loss on disposal (88) (18) (62)
Loss on early extinguishment of debt 0 (23) (3)
Other income, net 36 20 32
Income from continuing operations before income taxes 337 391 734
Income tax (expense) benefit (46) 38 (45)
Income from continuing operations 291 429 689
Income (loss) from discontinued operations, net of tax 775 169 (39)
Net income 1,066 598 650
Net income attributable to noncontrolling interests (32) (36) (313)
Net (loss) income 1,034 562 337
Huntsman International LLC [Member]      
Operating Activities:      
Net income 1,067 587 636
Less: (Income) loss from discontinued operations, net of tax (775) (169) 39
Income from continuing operations 292 418 675
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Equity in income of investment in unconsolidated affiliates (42) (54) (55)
Unrealized losses on fair value adjustments to Venator investment and related loss on disposal 88 19 62
Cash received from return on investment in unconsolidated subsidiary 19 24 0
Depreciation and amortization 283 270 252
Noncash lease expense 63 55 0
(Gain) loss on disposal of businesses/assets (281) (49) 3
Loss on early extinguishment of debt 0 23 3
Noncash restructuring and impairment charges (credits) 7 3 (22)
Deferred income taxes 172 (91) (172)
Other, net 8 36 26
Noncash compensation 26 28 26
Changes in operating assets and liabilities:      
Accounts and notes receivable 100 138 (23)
Inventories 145 77 (80)
Prepaid expenses (9) (27) (8)
Other current assets (56) 48 59
Other noncurrent assets (55) (90) (41)
Accounts payable 30 7 (9)
Accrued liabilities (126) (51) 44
Taxes paid on Chemical Intermediates Businesses (231) 0 0
Other noncurrent liabilities (154) (139) (53)
Net cash provided by operating activities from continuing operations 279 645 687
Net cash (used in) provided by operating activities from discontinued operations (24) 241 503
Net cash provided by operating activities 255 886 1,190
Investing Activities:      
Capital expenditures (249) (274) (251)
Cash received from sale of businesses 2,181 0 0
Cash received from the sale of Venator shares 99 0 0
Acquisition of businesses, net of cash acquired (650) 0 (366)
Proceeds from sale of assets 75 50 0
Cash received from forward swap contract related to the sale of investment in Venator 0 16 3
Other 7 7 0
Net cash provided by (used in) investing activities from continuing operations 1,736 (202) (630)
Net cash provided by (used in) investing activities from discontinued operations 1 (59) (358)
Net cash provided by (used in) investing activities 1,737 (261) (988)
Increase in receivable from affiliate 273 (1) (16)
Financing Activities:      
Net (repayments) borrowings on revolving loan facilities (203) (89) 125
Repayments of long-term debt (21) (676) (68)
Proceeds from issuance of long-term debt 0 742 0
Repayments of short-term debt (109) 0 (8)
Borrowings on short-term debt 0 102 6
Repayments of notes payable (32) (27) (29)
Borrowings on note payable 0 37 27
Debt issuance costs paid 0 (8) (4)
Costs of early extinguishment of debt 0 (21) 0
Dividends paid to noncontrolling interests (44) (41) (69)
Cash paid for noncontrolling interest 0 (101) 0
Proceeds from the secondary offering of Venator 0 0 44
Other 0 (1) (5)
Net cash used in financing activities (933) (438) (390)
Effect of exchange rate changes on cash 7 (2) (35)
Increase (decrease) in cash, cash equivalents and restricted cash 1,066 185 (223)
Cash, cash equivalents and restricted cash from continuing operations at beginning of period 525 340 479
Cash, cash equivalents and restricted cash from discontinued operations at beginning of period 0 0 238
Deconsolidation of cash, cash equivalents and restricted cash from Venator 0 0 (154)
Cash, cash equivalents and restricted cash at end of period 1,591 525 340
Repayments of notes payable to affiliate (380) (207) (255)
Dividends paid to parent (144) (148) (154)
Supplemental cash flow information:      
Cash paid for interest 90 111 163
Cash paid for income taxes 316 100 179
Revenues:      
Total revenues 6,018 6,797 7,604
Cost of goods sold 4,918 5,415 5,837
Gross profit 1,100 1,382 1,767
Operating expenses:      
Selling, general and administrative 769 781 784
Research and development 135 137 145
Restructuring, impairment and plant closing costs (credits) 49 (41) (7)
Merger costs 0 0 2
Gain on sale of India-based DIY business (247) 0 0
Other operating (income) expense, net (45) 31 8
Total operating expenses 661 908 932
Operating income 439 474 835
Interest expense, net (88) (126) (136)
Equity in income of investment in unconsolidated affiliates 42 54 55
Fair value adjustments to Venator investment and related loss on disposal (88) (18) (62)
Loss on early extinguishment of debt 0 (23) (3)
Other income, net 33 16 27
Income from continuing operations before income taxes 338 377 716
Income tax (expense) benefit (46) 41 (41)
Income from continuing operations 292 418 675
Income (loss) from discontinued operations, net of tax 775 169 (39)
Net income 1,067 587 636
Net income attributable to noncontrolling interests (32) (36) (313)
Net (loss) income 1,035 551 323
Third Party Customers [Member]      
Revenues:      
Total revenues 5,903 6,664 7,451
Third Party Customers [Member] | Huntsman International LLC [Member]      
Revenues:      
Total revenues 5,903 6,664 7,451
Related Party Customers [Member]      
Revenues:      
Total revenues 115 133 153
Related Party Customers [Member] | Huntsman International LLC [Member]      
Revenues:      
Total revenues $ 115 $ 133 $ 153
[1] Geographic information for revenues is based upon countries into which product is sold.